GLP-2 COMPOUNDS, FORMULATIONS, AND USES THEREOF

Details for Australian Patent Application No. 2003273761 (hide)

Owner NOVO NORDISK A/S

Inventors Nielsen, Anette Sams; Engelund, Dorthe Kot; Madsen, Kjeld; Thim, Lars; Bang, Susanne; Schlein, Morten; Kaarsholm, Niels Christian; Johansen, Nils Langeland; Thygesen, Peter; Zundel, Magali

Agent Shelston IP

Pub. Number AU-A-2003273761

PCT Number PCT/DK03/00694

PCT Pub. Number WO2004/035624

Priority PA 2002 01574 14.10.02 DK; PA 2002 01780 19.11.02 DK; PA 2002 01778 19.11.02 DK

Filing date 14 October 2003

Wipo publication date 4 May 2004

International Classifications

C07K 014/605 Peptides having more than 20 amino acids

Event Publications

12 February 2004 Complete Application Filed

  Priority application(s): PA 2002 01574 14.10.02 DK; PA 2002 01780 19.11.02 DK; PA 2002 01778 19.11.02 DK

10 June 2004 Application Open to Public Inspection

  Published as AU-A-2003273761

7 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003273762-USE OF GLYCOGEN PHOSPHORYLASE INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISEASES

2003273760-Methods and apparatus for harvesting vaccine from eggs